Projects per year
Abstract
Translation is fundamental for many biologic processes as it enables cells to rapidly respond to stimuli without requiring de novo mRNA synthesis. The mammalian/mechanistic target of rapamycin (mTOR) is a key regulator of translation. Although mTOR affects global protein synthesis, translation of a subset of mRNAs appears to be exceptionally sensitive to changes in mTOR activity. Recent efforts to catalog these mTOR-sensitive mRNAs resulted in conflicting results. Whereas ribosome-profiling almost exclusively identified 5′-terminal oligopyrimidine (TOP) mRNAs as mTOR-sensitive, polysome-profiling suggested that mTOR also regulates translation of non-TOP mRNAs. This inconsistency was explained by analytical and technical biases limiting the efficiency of ribosome-profiling in detecting mRNAs showing differential translation. Moreover, genome-wide characterization of 5′UTRs of non-TOP mTOR-sensitive mRNAs revealed 2 subsets of transcripts which differ in their requirement for translation initiation factors and biologic functions. We summarize these recent advances and their impact on the understanding of mTOR-sensitive translation.
Original language | English |
---|---|
Pages (from-to) | 1299-1305 |
Number of pages | 7 |
Journal | RNA Biology |
Volume | 14 |
Issue number | 10 |
DOIs | |
Publication status | Published - 3 Oct 2017 |
Keywords
- eIFs
- mRNA translation
- mTOR
- nanoCAGE
- polysome profiling
- ribosome profiling
- UTR
Projects
- 1 Finished
-
Novel combination therapies targeting the ribosome to treat prostate cancer
Furic, L. (Primary Chief Investigator (PCI)), Daly, R. (Chief Investigator (CI)), Hannan, R. (Chief Investigator (CI)), Risbridger, G. (Chief Investigator (CI)), Pearson, R. D. (Partner Investigator (PI)) & Sandhu, S. K. (Partner Investigator (PI))
1/05/15 → 30/04/18
Project: Research